StockData
Oculis Holding AG logo

Oculis Holding AG (OCS) stock

OCSNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as OCSAW
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 20-F on Mar 4, 2026Score 1/30
$7.39−0.12 (-1.60%)

Close on Nov 18, 2026Market cap $444.06MP/E –Yield –

Oculis revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

No revenue figures for Oculis

Oculis has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More Oculis figures

See a number that looks wrong?